Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report
- 12 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Journal of Gastroenterology
- Vol. 14 (1), 251-257
- https://doi.org/10.1007/s12328-020-01286-2
Abstract
Multidisciplinary treatment is recommended for the management of patients with advanced hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding arteries with laparotomy have been introduced for HCC. We herein newly develop laparoscopic devascularization (LDEV) to continue transarterial chemoembolization (TACE) for HCC with extrahepatic collateral arteries. A 74-year-old man with multiple huge HCC (4 tumors, 18 cm in diameter) and poor liver function (non-alcoholic steatohepatitis, Child–Pugh score 7) was treated with 6 times of chemoembolization in combination with LDEV, 3 times of ablation therapies, and lenvatinib therapy. His tumor markers were triple positive (AFP, 12,906.5 ng/ml; PIVKA-II, 491,743 mAU/ml; AFP-L3, 91.8%) before treatments; however, they all returned to normal limits. Complete response was achieved according to the modified RECIST criteria. Unfortunately, he died 6 months after the final treatment with no recurrence of HCC due to the postoperative complication of primary lung cancer. LDEV is a useful tool to continue effective TACE, and multidisciplinary treatment including chemoembolization and LDEV can cure advanced HCC patients with extrahepatic collaterals and impaired liver function.Keywords
This publication has 27 references indexed in Scilit:
- Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort studyMedical Oncology, 2015
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinomaBritish Journal of Cancer, 2014
- Building the Multidisciplinary Team for Management of Patients With Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2014
- Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular CarcinomaJournal of Gastrointestinal Cancer, 2012
- Chemoembolization for intermediate HCC: Is there proof of survival benefit?Journal of Hepatology, 2012
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patientWorld Journal of Gastroenterology, 2009
- Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinomaWorld Journal of Gastroenterology, 2005
- Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institutionJournal of Hepatology, 1998